Canaccord Genuity Downgrades Pharmasset (VRUS) to 'Hold' Following Announced Acquisition
Go back to Canaccord Genuity Downgrades Pharmasset (VRUS) to 'Hold' Following Announced Acquisition| Gilead Sciences (NASDAQ: GILD) | Delayed: 137.57 -0.79 (0.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.36 | 52 Week High | $108.63 | |||
| Open | $138.36 | 52 Week Low | $71.39 | |||
| Day High | $138.38 | P/E | 76.01 | |||
| Day Low | $136.63 | EPS | $1.81 | |||
| Volume | 302,023 | |||||
| Pharmasset, Inc. (AMEX: VRUS) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $137.81 | |||
| Open | $67.86 | 52 Week Low | $46.49 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-1.25 | |||
| Volume | 34,954 | |||||
